Japan’s First Long-Acting Injectable HIV Drug Holds Great Promise: ViiV Local Chief

ViiV Healthcare Japan President Simon Lee ViiV Healthcare’s Vocabria (cabotegravir) hit the Japan market this June as the country’s first long-acting injectable treatment for HIV. Thanks to its less frequent dosing compared to daily oral regimens, the drug has drawn...read more